Kelly C. Rowe, Ph.D.

Affiliations: 
2011 Neuroscience University of Iowa, Iowa City, IA 
Area:
Neuroscience Biology, Psychobiology Psychology, Physiology Biology
Google:
"Kelly Rowe"
Mean distance: 42746.4
 

Parents

Sign in to add mentor
David J. Moser grad student 2011 University of Iowa
 (Beyond the cortex: Implications of white matter connectivity for depression, cognition, and vascular disease.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Beglinger LJ, Prest L, Mills JA, et al. (2012) Clinical predictors of driving status in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1146-52
Rowe KC, Paulsen JS, Langbehn DR, et al. (2012) Patterns of serotonergic antidepressant usage in prodromal Huntington disease. Psychiatry Research. 196: 309-14
Stillman AN, Rowe KC, Arndt S, et al. (2012) Anxious symptoms and cognitive function in non-demented older adults: an inverse relationship. International Journal of Geriatric Psychiatry. 27: 792-8
Downing N, Smith MM, Beglinger LJ, et al. (2012) Perceived stress in prodromal Huntington disease. Psychology & Health. 27: 196-209
Timpe JC, Rowe KC, Matsui J, et al. (2011) White matter integrity, as measured by diffusion tensor imaging, distinguishes between impaired and unimpaired older adult decision-makers: A preliminary investigation. Journal of Cognitive Psychology (Hove, England). 23: 760-767
O'Rourke JJ, Beglinger LJ, Smith MM, et al. (2011) The Trail Making Test in prodromal Huntington disease: contributions of disease progression to test performance. Journal of Clinical and Experimental Neuropsychology. 33: 567-79
Rowe KC, Paulsen JS, Langbehn DR, et al. (2010) Self-paced timing detects and tracks change in prodromal Huntington disease. Neuropsychology. 24: 435-42
ROWE K, BEGLINGER L, WANG C, et al. (2009) Poster 16: Antidepressant Use in PREDICT-HD: Patterns of Use Relevant to “Naturalistic” Drug Studies Neurotherapeutics. 6: 209-209
See more...